工具
选股器
从StockVane跟踪的3753只美股大盘股中筛选,并可按任意列排序。结果中的量化评级与个股页面上显示的一致。
9 个匹配结果
| 公司 | 60日 | 最新价 | 涨跌幅 | 市值 | 市盈率 | 股息率 | 近一年 | 量化评级 ↓ |
|---|---|---|---|---|---|---|---|---|
| Eli Lilly and CoLLY | 1,257.03 | +0.43% | $1.18T | 42.20 | 0.51% | +57.6% | B 85 | |
| AmgenAMGN | 432.49 | -0.35% | $233.82B | 26.86 | 2.27% | +48.8% | B 83 | |
| Organon & CoOGN | 13.76 | 0.00% | $3.61B | 17.64 | 0.58% | +49.5% | B 81 | |
| Bristol-Myers SquibbBMY | 59.75 | -1.35% | $122.05B | 13.16 | 4.20% | +41.6% | B 79 | |
| AbbVieABBV | 285.42 | +0.71% | $504.37B | 80.63 | 2.36% | +27.3% | C 70 | |
| Novartis AGNVS | 150.62 | +0.16% | $286.29B | 22.75 | 3.15% | +18.1% | C 59 | |
| AstraZenecaAZN | 165.41 | -0.76% | $256.54B | 24.76 | 1.91% | -0.7% | D 37 | |
| GrifolsGRFS | 7.64 | +1.33% | $5.20B | 10.31 | 3.64% | -19.8% | D 20 | |
| Novo-Nordisk A/SNVO | 38.83 | -0.99% | $173.38B | 9.87 | 4.65% | -25.1% | E 14 |
仅供参考,不构成投资建议。筛选结果是研究的起点,而非买入清单。量化评级方法详见数据与方法说明。